Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Immunocore Holdings plc - American Depositary Shares
(NQ:
IMCR
)
32.75
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Immunocore Holdings plc - American Depositary Shares
< Previous
1
2
3
4
5
6
7
Next >
Immunocore (IMCR) Q2 2025 Earnings Call Transcript
↗
November 27, 2025
Immunocore (IMCR) Q2 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Immunocore to present at upcoming investor conferences
November 10, 2025
From
Immunocore Holdings plc
Via
GlobeNewswire
Immunocore presents Phase 1 data for hepatitis B candidate at AASLD’s The Liver Meeting
November 07, 2025
From
Immunocore Holdings plc
Via
GlobeNewswire
Earnings Scheduled For August 7, 2025
↗
August 07, 2025
Via
Benzinga
Demystifying Immunocore Holdings: Insights From 9 Analyst Reviews
↗
June 02, 2025
Via
Benzinga
What Analysts Are Saying About Immunocore Hldgs Stock
↗
February 27, 2025
Via
Benzinga
Earnings Scheduled For February 26, 2025
↗
February 26, 2025
Via
Benzinga
Analyst Expectations For Immunocore Hldgs's Future
↗
January 27, 2025
Via
Benzinga
Immunocore reports third quarter financial results and provides a business update
November 06, 2025
From
Immunocore Holdings plc
Via
GlobeNewswire
Growth Picks: 3 Low-Cost Stocks That Could Double in Value
↗
October 27, 2025
Via
MarketBeat
Immunocore to present at upcoming investor conferences
September 04, 2025
From
Immunocore Holdings plc
Via
GlobeNewswire
Immunocore (IMCR) Q2 Revenue Jumps 30%
↗
August 07, 2025
Via
The Motley Fool
Topics
Earnings
Intellectual Property
Immunocore Holdings PLC (NASDAQ:IMCR) Beats Q2 2025 Revenue and EPS Estimates with Strong KIMMTRAK Sales Growth
↗
August 07, 2025
Immunocore (IMCR) beat Q2 2025 estimates with $98M revenue (+30% YoY) and a narrower EPS loss. KIMMTRAK sales surged 32%, while pipeline progress and strong cash position ($882.8M) boosted investor...
Via
Chartmill
Immunocore reports second quarter financial results and provides a business update
August 07, 2025
From
Immunocore Holdings plc
Via
GlobeNewswire
Immunocore to report second quarter 2025 financial results and host call on August 7, 2025
July 31, 2025
From
Immunocore Holdings plc
Via
GlobeNewswire
Immunocore to present at the 2025 Jefferies Global Healthcare Conference
June 02, 2025
From
Immunocore Holdings plc
Via
GlobeNewswire
Immunocore reports first quarter financial results and provides a business update
May 07, 2025
From
Immunocore Holdings plc
Via
GlobeNewswire
Analyst Expectations For Immunocore Holdings's Future
↗
April 07, 2025
Via
Benzinga
Immunocore to present at upcoming investor conferences
April 02, 2025
From
Immunocore Holdings plc
Via
GlobeNewswire
Jabil Posts Better-Than-Expected Earnings, Joins Darden Restaurants, QXO, Five Below And Other Big Stocks Moving Higher On Thursday
↗
March 20, 2025
Via
Benzinga
Immunocore presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025
March 10, 2025
From
Immunocore Holdings plc
Via
GlobeNewswire
Immunocore to present at upcoming investor conferences
March 03, 2025
From
Immunocore Holdings plc
Via
GlobeNewswire
Immunocore reports fourth quarter and full year 2024 financial results and provides a business update
February 26, 2025
From
Immunocore Holdings plc
Via
GlobeNewswire
Immunocore to report fourth quarter and full year 2024 financial results and host call on February 26, 2025
February 19, 2025
From
Immunocore Holdings plc
Via
GlobeNewswire
Immunocore announces strategic priorities at 43rd Annual J.P. Morgan Healthcare Conference
January 10, 2025
From
Immunocore Holdings plc
Via
GlobeNewswire
Immunocore to present at the 43rd Annual J.P. Morgan Healthcare Conference
January 06, 2025
From
Immunocore Holdings plc
Via
GlobeNewswire
Immunocore appoints Travis Coy, previously a Non-Executive Director, as its EVP, Chief Financial Officer and Head of Corporate Development
January 02, 2025
From
Immunocore Holdings plc
Via
GlobeNewswire
Immunocore announces first patient dosed in the Phase 1 trial of IMC-P115C, a half-life extended (HLE) ImmTAC candidate in patients with tumors that express PRAME
December 23, 2024
From
Immunocore Holdings plc
Via
GlobeNewswire
Immunocore announces treatment of first patient in the Phase 1/2 trial of IMC-R117C targeting PIWIL1 in advanced gastrointestinal cancers
December 17, 2024
From
Immunocore Holdings plc
Via
GlobeNewswire
Why Are Amicus, Immunocore, & Immuneering Stocks Trading Lower On Friday?
↗
December 13, 2024
Morgan Stanley downgrades Amicus Therapeutics, Immunocore, and Immuneering, citing pricing challenges, pipeline updates, and cautious growth outlooks.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
